Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,317,626 papers from all fields of science
Search
Sign In
Create Free Account
1-phenylcyclopropylamine
Known as:
1-PCPA
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Cyclopropanes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Abstracts from the Millennium Amine Oxidases Meeting
J. Shih
,
L. Oreland
,
H. Garpenstrand
,
J. Hallman
InflammoPharmacology
2004
Corpus ID: 347861
s of the Millennium Amine Oxidases Meeting 269 Part 1: Invited oral communications Biochemical and molecular aspects of monoamine…
Expand
2001
2001
Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N.
D. Mitchell
,
D. Nikolić
,
+5 authors
R. Silverman
Biochemistry
2001
Corpus ID: 31679491
1-Phenylcyclopropylamine (1-PCPA) is shown to be an inactivator of the fungal flavoenzyme monoamine oxidase (MAO) N. Inactivation…
Expand
2001
2001
Inactivation of C30A trimethylamine dehydrogenase by N-cyclopropyl-alpha-methylbenzylamine, 1-phenylcyclopropylamine, and phenylhydrazine.
D. Mitchell
,
D. Nikolić
,
M. Jang
,
R. V. van Breemen
,
R. Hille
,
R. Silverman
Biochemistry
2001
Corpus ID: 27020910
Trimethylamine dehydrogenase (TMADH) from the bacterium Methylophilus methylotrophus (sp. W(3)A(1)) and its C30A mutant were…
Expand
2001
2001
Inactivation of monoamine oxidase B by 1-phenylcyclopropylamine: mass spectral evidence for the flavin adduct.
Deanna J. Mitchell
,
D. Nikolić
,
R. Breemen
,
Richard B. Silverman
Bioorganic & Medicinal Chemistry Letters
2001
Corpus ID: 10815822
1985
1985
Mechanism-based inactivation of monoamine oxidase by 1-phenylcyclopropylamine
R. Silverman
,
P. Zieske
1985
Corpus ID: 90410393
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE